Terauchi, Y., Tamura, M., Senda, M., Gunji, R., & Kaku, K. (2018). Long‐term safety and efficacy of tofogliflozin as add‐on to insulin in patients with type 2 diabetes: Results from a 52‐week, multicentre, randomized, double‐blind, open‐label extension, Phase 4 study in Japan (J‐STEP/INS). Diabetes Obes Metab.

Terauchi, Yasuo, Masahiro Tamura, Masayuki Senda, Ryoji Gunji, and Kohei Kaku. "Long‐term Safety and Efficacy of Tofogliflozin As Add‐on to Insulin in Patients With Type 2 Diabetes: Results From a 52‐week, Multicentre, Randomized, Double‐blind, Open‐label Extension, Phase 4 Study in Japan (J‐STEP/INS)." Diabetes Obes Metab 2018.

Terauchi, Yasuo, et al. "Long‐term Safety and Efficacy of Tofogliflozin As Add‐on to Insulin in Patients With Type 2 Diabetes: Results From a 52‐week, Multicentre, Randomized, Double‐blind, Open‐label Extension, Phase 4 Study in Japan (J‐STEP/INS)." Diabetes Obes Metab 2018.